Hillel Alapi

669 total citations
11 papers, 382 citations indexed

About

Hillel Alapi is a scholar working on Infectious Diseases, Genetics and Health. According to data from OpenAlex, Hillel Alapi has authored 11 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Genetics and 3 papers in Health. Recurrent topics in Hillel Alapi's work include SARS-CoV-2 and COVID-19 Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and COVID-19 epidemiological studies (3 papers). Hillel Alapi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and COVID-19 epidemiological studies (3 papers). Hillel Alapi collaborates with scholars based in Israel and United States. Hillel Alapi's co-authors include Gabriel Chodick, Sivan Gazit, Tal Patalon, Esma Herzel, Idan Yelin, Roy Kishony, Jacob Kuint, Matan Levine-Tiefenbrun, Rachel Katz and Roni Lotan and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Hillel Alapi

10 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hillel Alapi Israel	7	288	111	84	36	36	11	382
Renuka Kadali United States	6	223 0.8×	120 1.1×	22 0.3×	25 0.7×	15 0.4×	7	364
Maria Elena Spoltore Italy	6	193 0.7×	39 0.4×	19 0.2×	17 0.5×	40 1.1×	8	280
Rebecca Rossetti Italy	5	193 0.7×	38 0.3×	19 0.2×	15 0.4×	39 1.1×	9	276
Kathie G. Ferbas United States	7	231 0.8×	186 1.7×	61 0.7×	29 0.8×	21 0.6×	11	313
Lilac Tene Israel	5	202 0.7×	107 1.0×	56 0.7×	14 0.4×	12 0.3×	10	272
Joel W. Jones United States	7	165 0.6×	70 0.6×	63 0.8×	31 0.9×	19 0.5×	21	250
Mélanie Closset Belgium	8	314 1.1×	64 0.6×	38 0.5×	36 1.0×	15 0.4×	30	431
Shuying Luo China	11	99 0.3×	104 0.9×	30 0.4×	36 1.0×	108 3.0×	32	342
Noosha Samieefar Iran	7	100 0.3×	58 0.5×	25 0.3×	30 0.8×	22 0.6×	31	271
Karine Beiruti Wiegler Israel	6	245 0.9×	65 0.6×	42 0.5×	15 0.4×	17 0.5×	19	340

Countries citing papers authored by Hillel Alapi

Since Specialization

Citations

This map shows the geographic impact of Hillel Alapi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillel Alapi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillel Alapi more than expected).

Fields of papers citing papers by Hillel Alapi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillel Alapi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillel Alapi. The network helps show where Hillel Alapi may publish in the future.

Co-authorship network of co-authors of Hillel Alapi

This figure shows the co-authorship network connecting the top 25 collaborators of Hillel Alapi. A scholar is included among the top collaborators of Hillel Alapi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillel Alapi. Hillel Alapi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Cohen, Yaël C., et al.. (2024). Clinical significance of FLC tests in patients without other evidence of hematologic disorder. Clinical and Experimental Medicine. 24(1). 198–198.

Tadmor, Tamar, et al.. (2024). Vitamin D supplement for patients with early-stage chronic lymphocytic leukemia is associated with a longer time to first treatment. Blood Advances. 8(14). 3840–3846. 1 indexed citations

Siegelmann‐Danieli, Nava, Victoria Neiman, Avital Bareket‐Samish, et al.. (2023). Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate. 84(1). 39–46. 2 indexed citations

Hazan, Guy, Or Duek, Hillel Alapi, et al.. (2023). Biological rhythms in COVID-19 vaccine effectiveness in an observational cohort study of 1.5 million patients. Journal of Clinical Investigation. 133(11). 27 indexed citations

Tadmor, Tamar, Hillel Alapi, & Lior Rokach. (2023). Effectiveness of nirmatrelvir plus ritonavir treatment for patients with CLL during the Omicron Surge. Blood. 141(18). 2239–2244. 7 indexed citations

Tadmor, Tamar, et al.. (2023). Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia. Acta Haematologica. 146(5). 379–383. 1 indexed citations

Gazit, Sivan, Galit Perez, Roni Lotan, et al.. (2022). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study. Clinical Infectious Diseases. 75(1). e545–e551. 90 indexed citations

Levine-Tiefenbrun, Matan, Idan Yelin, Hillel Alapi, et al.. (2022). Waning of SARS-CoV-2 booster viral-load reduction effectiveness. Nature Communications. 13(1). 1237–1237. 42 indexed citations

Gazit, Sivan, Galit Perez, Roni Lotan, et al.. (2022). The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine. Annals of Internal Medicine. 175(5). 674–681. 39 indexed citations

10.

Levine-Tiefenbrun, Matan, Idan Yelin, Hillel Alapi, et al.. (2021). Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Nature Medicine. 27(12). 2108–2110. 139 indexed citations

11.

Chodick, Gabriel, Avi Porath, Hillel Alapi, et al.. (2010). The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel. Health Policy. 95(2-3). 271–276. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact